The US Federal Food and Drug Administration (FDA) inspected the good manufacturing practices of Biocon's new active pharmaceutical ingredients (API) facility near Hyderabad in Telangana last week, said the biotech firm on Monday.
"The US FDA conducted a GMP inspection of our APIs manufacturing facility near Hyderabad from December 12-14 and concluded without any observation," said the city-based pharma major in a statement here.
--IANS
fb/mr
Disclaimer: No Business Standard Journalist was involved in creation of this content
